Extract: High passage Cendehill strain of rubella virus, possesing in vivo and in vitro characteristics of an attenuated virus, was tested for efficacy in 28 seronegative infants, 3 to 23 months old.
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a biotechnology company commercializing a novel vaccination platform, today announced that it has received a US$5 million [AU$7.5 ...
A single dose of measles and rubella (MR) vaccine delivered to adults by the Vaxxas high-density microarray patch (HD-MAP) provided antibody responses comparable to the same vaccine delivered by ...
DURING the winter and spring of 1964 the United States experienced the largest epidemic of rubella recorded during the past twenty years. 1 In Connecticut over 40,000 cases were reported to the State ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results